Search About Owlstone Medical is developing a breathalyzer for disease. Our mission is to save 100,000 lives and $1.5B in healthcare costs by advancing early detection and precision medicine. SCROLL Non-invasive breath biomarkers for early detection and precision medicine Owlstone Medical is developing a breathalyzer for disease. With a goal to find ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health and other conditions. Our mission is to save 100,000 lives and $1.5B in healthcare costs by advancing early detection and precision medicine. Breath Biopsy® aims to develop a new diagnostic modality making it possible to discover novel non-invasive biomarkers in breath using a platform with the potential to transition to point-of-care. The award-winning ReCIVA® Breath Sampler ensures reliable collection of breath samples. The volatile organic compounds (VOCs) present in breath are analyzed using state of the art chemical analysis technologies. Our aim is to develop tools, potentially based on our proven microchip chemical sensor technology (FAIMS), to detect validated biomarkers of disease. The Breath Biopsy platform provides biomarker discovery and validation capabilities to support development of applications in precision medicine for a wide range of other medical conditions. Highly sensitive and selective, our platform allows for early diagnosis when treatments are more effective and more lives can be saved. Owlstone Medical is involved in studies related to major and rapidly growing health concerns including lung cancer, asthma and liver disease. We are also participants in extensive partnerships focusing on multiple cancer types, pulmonary hypertension, mesothelioma, workplace exposures and much more. Our Breath Biopsy Products and Services are available to academic, clinical and pharma research partners who want to develop breath based diagnostics for their own applications. We are scientists, doctors, engineers and entrepreneurs on a mission to save lives through early detection of disease MEET OUR TEAM At Owlstone Medical, everyone makes a difference We are on a mission to save 100k lives and $1.5Bn healthcare costs. We can only do this if we have the very best scientists and engineers. If that is you, we would love to hear from you.... VIEW JOB VACANCIES Our latest updates OMNI: Reproducible Non-invasive Global VOC Analysis of Breath 29 Nov 21 BREATH BIOPSY Leaders in the Field: Kevin Lamote on building a career in breath research 22 Nov 21 BREATH BIOPSY Standardization and data sharing at the #BBCon21 panel discussion 08 Nov 21 BREATH BIOPSY Breath Biopsy Conference 2021: Progress through standardization 15 Oct 21 BREATH BIOPSY Inflammation as a Source of Disease Biomarkers 04 Oct 21 BREATH BIOPSY The Need for Breath Tests in Gut Health 27 Sep 21 VIEW ALL NEWS Let's work together to advance early detection and precision medicine through Breath Biopsy. GET IN TOUCH TODAY Owlstone Medical is developing a breathalyzer for disease for the early detection of cancer, inflammatory and infectious disease. Our mission is to save 100,000 lives and $1.5B in healthcare costs. CONTACTS Cambridge, UK (Visiting): +44 (0)1223 428200 Cambridge, UK: +44 (0)1223 428200 North Carolina, USA: 984-244-7811 Connecticut, USA: +1 203-908-4848 Get in touch with us CONNECT WITH US CONTACT US Twitter LinkedIn Facebook Owlstone Medical's Products and Services are for research use only. Not for use in diagnostic procedures. © Owlstone Medical Ltd 2021 Privacy Policy Cookie Policy Legal Notice and Other Policies Designed & built by Onespacemedia